Skip to content
Search

Latest Stories

NHS England chief Amanda Pritchard steps down, Sir James Mackey named successor

Sir James Mackey will formally take over as NHS England's chief executive on 1 April.

NHS England chief Amanda Pritchard steps down

Amanda Pritchard

REUTERS

Amanda Pritchard has announced her decision to stand down as chief executive of NHS England at the end of this financial year.

Pritchard, who has led NHS England since August 2021, made history as the first woman to hold the post, playing a pivotal role in steering the NHS through the Covid-19 pandemic. Previously, she served as chief operating officer from 2019.


Before joining NHS England, she served as chief executive of Guy’s and St Thomas’ NHS Foundation Trust, deputy chief executive at Chelsea and Westminster NHS Foundation Trust and a health team leader in the Prime Minister’s Delivery Unit.

In a statement, Pritchard said the decision came after months of discussions with the secretary of state for health and social care.

“While it has been a hugely difficult decision for me to stand down, I believe now is the right time – with the NHS making continued progress in our recovery, and with the foundations firmly in place to deliver the 10 Year Health Plan,” she said.

Her departure follows scrutiny from two influential House of Commons committees less than a month ago, which discussed her suitability to lead the NHS through what prime minister Keir Starmer has described as the most significant overhaul of the health service.

Sir James Mackey will take over as Transition CEO, working closely with Pritchard over the next month before officially assuming the role on 1 April.

Currently, he serves as chief executive of Newcastle Hospitals NHS Foundation Trust and national director of Elective Recovery. Mackey previously served as chief executive of NHS Improvement.

Mackey acknowledged Pritchard’s significant contributions, stating, “Amanda has done an extraordinary job of leading the NHS through this difficult period.”

He added: I have always been very proud to work for the NHS and it will be an honour to lead the service through the next phase as we radically reshape the role of NHS England and work with the Government to build an NHS that is fit for the future through the 10 Year Health Plan.

Mackey also expressed gratitude to Newcastle Hospitals, where he has been chief executive for the past 14 months.

He said: “I am sad to be stepping away from Newcastle Hospitals, and it has been a privilege to be part of the dedicated and talented team there over the last 14 months. I have learned a great deal from colleagues there as we have successfully tackled some difficult issues and made significant improvements. I look forward to rejoining them in due course.”

Health secretary Wes Streeting praised Amanda’s leadership during the biggest health emergency in modern history.

He also applauded her for steering NHS England during “turbulent political waters and six secretaries of state” in her time as chief executive.

“She has led with integrity and unwavering commitment,” he said.

Streeting also expressed confidence in Mackey’s leadership, stating: “He knows the NHS inside out, can see how it needs to change, and will work with the speed and urgency we need.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less